UNSPSC 51342309: Aciclovir or acyclovir

This classification denotes a purine antagonist and antiviral agent with the molecular formula C8H11N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X4HES1O11F, chemically known as 6h-purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)- but generally known as aciclovir, which bears US NIH Compound Identifier 2022. Aciclovir, also known as acyclovir, most often comes in forms natrium and sodium.

UNSPSC 51342309 Aciclovir or acyclovir is a Commodity code that nominally addresses antiviral pharmaceuticals, but recent state and local solicitations tagged with this code show little alignment with aciclovir procurement. Instead, the opportunities posted under this code span a broader pharmaceutical and medical supply landscape: naloxone and drug deactivation systems for emergency response, direct-to-manufacturer prescription fulfillment programs, medical and first aid supplies for fire-rescue operations, and generic multi-source pharmaceuticals and OTC products through cooperative purchasing. The issuing bodies reflect the diversity of state and local health and safety operations — county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal purchasing for emergency services (City of Tampa Fire Department), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities across multiple states including Oregon). The code appears to capture pharmaceutical procurement broadly rather than aciclovir specifically, and the mismatch suggests either code assignment drift or use of this Commodity code as a catch-all for pharmaceutical product categories.

Recent opportunities span Florida, Texas, Minnesota, and Oregon. Representative solicitations include an IFB from Seminole County, Florida (IFB60459723LAS, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; a Request for Information from Texas HHS (HHS0017013, response deadline April 3, 2026) exploring direct-to-manufacturer prescription programs for self-insured state health plans; an IFB from the City of Tampa (26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, with an estimated contract value of $700,000 and a Small Local Business Enterprise set-aside; and an RFP from the Minnesota Multistate Cooperative Purchasing Alliance (S1070000015802, due March 26, 2026) to establish contracts for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, with awards effective July 1, 2026. The code shows fragmented activity across emergency response, state pharmacy programs, and cooperative purchasing rather than concentrated aciclovir demand.